Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sam L. Barker currently holds 36,810 shares of Cyclacel Pharmaceuticals, Inc. (CYCC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sam L. Barker has been a net buyer of CYCC stock. They have purchased $294.1K and sold $1.1K worth of shares.
Sam L. Barker's most recent insider trade was on May 13, 2024, when they sold 36,810 shares at $0.00 per share.
Sam L. Barker serves as Executive at Cyclacel Pharmaceuticals, Inc. (CYCC). They have executed 54 insider transactions totaling $295.2K over their tenure at the company.
Sam L. Barker holds the position of Executive at Cyclacel Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Sam L. Barker has shown a buying trading pattern, with $294.1K in total purchases and $1.1K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Sam L. Barker was on Mar 19, 2014, when they sold $280.0K worth of CADX shares. This transaction involved 20,000 shares at $14.00 per share.
Sam L. Barker currently owns 36,810 shares of Cyclacel Pharmaceuticals, Inc. (CYCC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sam L. Barker's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sam L. Barker has 54 Form 4 filings on record as an insider at Cyclacel Pharmaceuticals, Inc..
Set alerts for Sam L. Barker and 40,000+ other insiders.